Nexien BioPharma Inc – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 03/31/25 Q3

ended 12/31/24 Q2

ended 09/30/24 Q1

Late quarterly filing notification for Q1 2025

ended 06/30/24 FY 2024

Prospectuses and Registrations Filter

Securities registration termination

Initial registration of new securities – amended

Initial registration of new securities – amended

Initial registration of new securities

Correspondence regarding draft registration statement

Ownership Filter

Greenberg Richard S

Greenberg Richard S

Goldfarb Robert I

News Filter

Material Definitive Agreement, New Financial Obligation or Off-Balance Sheet Arrangement, Unregistered Sales of Equity Securities, Financial Statements or Exhibits

Has Been Issued a U.S. Patent for the Methods and Compositions for Treating Non-Dystrophic Myotonia and Myotonic Dystrophies Types 1 and 2

Change in Directors, Officers or Compensation

Change in Directors, Officers or Compensation

Announces That It Has Been Granted a Patent by the Israeli Patent Office Covering the Use of Cannabinoids and Terpenes for Treatment of Organophosphate and Carbamate Toxicity - Two Common Nerve Agents

Proxies Filter

Preliminary info

Other Filter

Notice of effectiveness

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Letter from the SEC